Copyright Reports & Markets. All rights reserved.

Global Cell Therapy and Tissue Engineering Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Cell Therapy
      • 1.4.3 Tissue Engineering
    • 1.5 Market by Application
      • 1.5.1 Global Cell Therapy and Tissue Engineering Market Share by Application (2019-2025)
      • 1.5.2 Cell Defects
      • 1.5.3 Genetic Diseases
      • 1.5.4 Neurodegenerative Diseases
      • 1.5.5 Tissue Malignancies
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Cell Therapy and Tissue Engineering Market Size
    • 2.2 Cell Therapy and Tissue Engineering Growth Trends by Regions
      • 2.2.1 Cell Therapy and Tissue Engineering Market Size by Regions (2019-2025)
      • 2.2.2 Cell Therapy and Tissue Engineering Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Cell Therapy and Tissue Engineering Market Size by by Players
      • 3.1.1 Global Cell Therapy and Tissue Engineering Revenue by by Players (2014-2019)
      • 3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Cell Therapy and Tissue Engineering Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cell Therapy and Tissue Engineering Key Players Head office and Area Served
    • 3.3 Key Players Cell Therapy and Tissue Engineering Product/Solution/Service
    • 3.4 Date of Enter into Cell Therapy and Tissue Engineering Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Cell Therapy and Tissue Engineering Market Size by Type (2014-2019)
    • 4.2 Global Cell Therapy and Tissue Engineering Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Cell Therapy and Tissue Engineering Market Size (2014-2019)
    • 5.2 Cell Therapy and Tissue Engineering Key Players in North America
    • 5.3 North America Cell Therapy and Tissue Engineering Market Size by Type
    • 5.4 North America Cell Therapy and Tissue Engineering Market Size by Application

    6 Europe

    • 6.1 Europe Cell Therapy and Tissue Engineering Market Size (2014-2019)
    • 6.2 Cell Therapy and Tissue Engineering Key Players in Europe
    • 6.3 Europe Cell Therapy and Tissue Engineering Market Size by Type
    • 6.4 Europe Cell Therapy and Tissue Engineering Market Size by Application

    7 China

    • 7.1 China Cell Therapy and Tissue Engineering Market Size (2014-2019)
    • 7.2 Cell Therapy and Tissue Engineering Key Players in China
    • 7.3 China Cell Therapy and Tissue Engineering Market Size by Type
    • 7.4 China Cell Therapy and Tissue Engineering Market Size by Application

    8 Japan

    • 8.1 Japan Cell Therapy and Tissue Engineering Market Size (2014-2019)
    • 8.2 Cell Therapy and Tissue Engineering Key Players in Japan
    • 8.3 Japan Cell Therapy and Tissue Engineering Market Size by Type
    • 8.4 Japan Cell Therapy and Tissue Engineering Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Cell Therapy and Tissue Engineering Market Size (2014-2019)
    • 9.2 Cell Therapy and Tissue Engineering Key Players in Southeast Asia
    • 9.3 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Type
    • 9.4 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Application

    10 India

    • 10.1 India Cell Therapy and Tissue Engineering Market Size (2014-2019)
    • 10.2 Cell Therapy and Tissue Engineering Key Players in India
    • 10.3 India Cell Therapy and Tissue Engineering Market Size by Type
    • 10.4 India Cell Therapy and Tissue Engineering Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Cell Therapy and Tissue Engineering Market Size (2014-2019)
    • 11.2 Cell Therapy and Tissue Engineering Key Players in Central & South America
    • 11.3 Central & South America Cell Therapy and Tissue Engineering Market Size by Type
    • 11.4 Central & South America Cell Therapy and Tissue Engineering Market Size by Application

    12 International Players Profiles

    • 12.1 Betalin Therapeutics
      • 12.1.1 Betalin Therapeutics Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Cell Therapy and Tissue Engineering Introduction
      • 12.1.4 Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2014-2019))
      • 12.1.5 Betalin Therapeutics Recent Development
    • 12.2 BioCardia, Inc
      • 12.2.1 BioCardia, Inc Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Cell Therapy and Tissue Engineering Introduction
      • 12.2.4 BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
      • 12.2.5 BioCardia, Inc Recent Development
    • 12.3 BioReliance Corporation
      • 12.3.1 BioReliance Corporation Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Cell Therapy and Tissue Engineering Introduction
      • 12.3.4 BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
      • 12.3.5 BioReliance Corporation Recent Development
    • 12.4 Biosolution Co., Ltd.
      • 12.4.1 Biosolution Co., Ltd. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Cell Therapy and Tissue Engineering Introduction
      • 12.4.4 Biosolution Co., Ltd. Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
      • 12.4.5 Biosolution Co., Ltd. Recent Development
    • 12.5 Brainstorm Cell Therapeutics, Inc
      • 12.5.1 Brainstorm Cell Therapeutics, Inc Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Cell Therapy and Tissue Engineering Introduction
      • 12.5.4 Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
      • 12.5.5 Brainstorm Cell Therapeutics, Inc Recent Development
    • 12.6 MaxCyte, Inc
      • 12.6.1 MaxCyte, Inc Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Cell Therapy and Tissue Engineering Introduction
      • 12.6.4 MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
      • 12.6.5 MaxCyte, Inc Recent Development
    • 12.7 Medigene AG
      • 12.7.1 Medigene AG Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Cell Therapy and Tissue Engineering Introduction
      • 12.7.4 Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
      • 12.7.5 Medigene AG Recent Development
    • 12.8 MEDIPOST CO., Ltd.
      • 12.8.1 MEDIPOST CO., Ltd. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Cell Therapy and Tissue Engineering Introduction
      • 12.8.4 MEDIPOST CO., Ltd. Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
      • 12.8.5 MEDIPOST CO., Ltd. Recent Development
    • 12.9 Mesoblast Limited
      • 12.9.1 Mesoblast Limited Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Cell Therapy and Tissue Engineering Introduction
      • 12.9.4 Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
      • 12.9.5 Mesoblast Limited Recent Development
    • 12.10 Miromatrix Medical, Inc.
      • 12.10.1 Miromatrix Medical, Inc. Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Cell Therapy and Tissue Engineering Introduction
      • 12.10.4 Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2014-2019)
      • 12.10.5 Miromatrix Medical, Inc. Recent Development
    • 12.11 MolMed S.p.A
    • 12.12 Mustang Bio, Inc
    • 12.13 NantKwest, Inc.
    • 12.14 Neuralstem, Inc
    • 12.15 NexImmune, Inc.
    • 12.16 Nohla Therapeutics, Inc
    • 12.17 ReNeuron Group plc
    • 12.18 Richter-Helm BioLogics GmbH & Co. KG
    • 12.19 RoosterBio, Inc
    • 12.20 RoslinCT
    • 12.21 Rubius Therapeutics, Inc.
    • 12.22 Sangamo Therapeutics, Inc
    • 12.23 Voyager Therapeutics, Inc
    • 12.24 Waisman Biomanufacturing
    • 12.25 WindMIL Therapeutics, Inc.
    • 12.26 Wuxi App Tec, Inc.
    • 12.27 ReNeuron Group plc
    • 12.28 Richter-Helm BioLogics GmbH & Co. KG
    • 12.28 RoosterBio, Inc
    • 12.40 RoslinCT

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules.
      Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules. Cell therapy, genetically modified cell therapy, gene therapy and tissue engineering are the four pillars of Regenerative Medicine (RM). These therapies have the potential to beneficially alter the quality of life and improve the health of patients with cell defects, genetic diseases, neurodegenerative diseases, tissue malignancies and other medical conditions.
      In 2018, the global Cell Therapy and Tissue Engineering market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Cell Therapy and Tissue Engineering status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell Therapy and Tissue Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Betalin Therapeutics
      BioCardia, Inc
      BioReliance Corporation
      Biosolution Co., Ltd.
      Brainstorm Cell Therapeutics, Inc
      MaxCyte, Inc
      Medigene AG
      MEDIPOST CO., Ltd.
      Mesoblast Limited
      Miromatrix Medical, Inc.
      MolMed S.p.A
      Mustang Bio, Inc
      NantKwest, Inc.
      Neuralstem, Inc
      NexImmune, Inc.
      Nohla Therapeutics, Inc
      ReNeuron Group plc
      Richter-Helm BioLogics GmbH & Co. KG
      RoosterBio, Inc
      RoslinCT
      Rubius Therapeutics, Inc.
      Sangamo Therapeutics, Inc
      Voyager Therapeutics, Inc
      Waisman Biomanufacturing
      WindMIL Therapeutics, Inc.
      Wuxi App Tec, Inc.
      ReNeuron Group plc
      Richter-Helm BioLogics GmbH & Co. KG
      RoosterBio, Inc
      RoslinCT

      Market segment by Type, the product can be split into
      Cell Therapy
      Tissue Engineering

      Market segment by Application, split into
      Cell Defects
      Genetic Diseases
      Neurodegenerative Diseases
      Tissue Malignancies
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Cell Therapy and Tissue Engineering status, future forecast, growth opportunity, key market and key players.
      To present the Cell Therapy and Tissue Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Cell Therapy and Tissue Engineering are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now